The biotechnology giant Genentech turned down a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.
The biotechnology giant Genentech turned down a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.